`

AffyImmune Therapeutics

Biotechnology

Specialities :
Oncology
Cart
Thyroidcancer
Gastriccancer
Celltherapy

+1

Sign Up to View More
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$20.0M
size-icon Size
11 - 50
About Us
Org Charts
Employees
Buyer Intent
Tech Stack
Jobs

Frequently Asked Questions About AffyImmune Therapeutics

What does Affyimmune therapeutics do?+

Founded in 2016, AffyImmune is a clinical-stage biotechnology company that optimizes CAR T cells for the treatment of solid tumors using our Tune & Track platform. AIC100, our first product, spares healthy cells through our unique affinity-tuning, enhancing its safety and efficacy. The initial indication for AIC100 is refractory thyroid cancer, which has a very poor prognosis and very few effective therapies. The antigen targeted by AIC100 is also overexpressed in a variety of additional cancers, including stomach, triple negative breast cancer and a number of others

What are Affyimmune therapeutics's specialties? +

Oncology,cart,thyroidcancer,gastriccancer,celltherapy,and cgt

What is Affyimmune therapeutics's industry? +

Affyimmune therapeutics operates in the Biotechnology industry.

What is Affyimmune therapeutics's revenue? +

Affyimmune therapeutics's revenue is 11m - 100m

What is Affyimmune therapeutics's company size? +

Affyimmune therapeutics has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Sign Up For Free
Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Sign Up For Free
Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.

Sign Up For Free